Global Cancer Gene Therapy Sales Market Report 2017

December 2017 | 122 pages | ID: G0C6F25FE57EN
QYResearch

Abstracts

In this report, the global Cancer Gene Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (Units), revenue (Million USD), market share and growth rate of Cancer Gene Therapy for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Cancer Gene Therapy market competition by top manufacturers/players, with Cancer Gene Therapy sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Adaptimmune
• GlaxoSmithKline
• Bluebird bio
• Merck
• Celgene
• Shanghai Sunway Biotech
• BioCancell
• Shenzhen SiBiono GeneTech
• SynerGene Therapeutics
• OncoGenex Pharmaceuticals
• Genelux Corporation
• Cell Genesys
• Advantagene
• GenVec
• BioCancell
• Celgene
• Epeius Biotechnologies
• Introgen Therapeutics
• Ziopharm Oncology
• Shenzhen SiBiono GeneTech
• Altor Bioscience

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Gene Induced Immunotherapy
• Oncolytic Virotherapy
• Gene Transfer

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Diagnostics Centers
• Research Institutes

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Cancer Gene Therapy Sales Market Report 2017

1 CANCER GENE THERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Gene Therapy
1.2 Classification of Cancer Gene Therapy by Product Category
  1.2.1 Global Cancer Gene Therapy Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Cancer Gene Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Gene Induced Immunotherapy
  1.2.4 Oncolytic Virotherapy
  1.2.5 Gene Transfer
1.3 Global Cancer Gene Therapy Market by Application/End Users
  1.3.1 Global Cancer Gene Therapy Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Diagnostics Centers
  1.3.4 Research Institutes
1.4 Global Cancer Gene Therapy Market by Region
  1.4.1 Global Cancer Gene Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.3 China Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.4 Europe Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.5 Japan Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Cancer Gene Therapy Status and Prospect (2012-2022)
  1.4.7 India Cancer Gene Therapy Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Cancer Gene Therapy (2012-2022)
  1.5.1 Global Cancer Gene Therapy Sales and Growth Rate (2012-2022)
  1.5.2 Global Cancer Gene Therapy Revenue and Growth Rate (2012-2022)

2 GLOBAL CANCER GENE THERAPY COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Cancer Gene Therapy Market Competition by Players/Suppliers
  2.1.1 Global Cancer Gene Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Cancer Gene Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Cancer Gene Therapy (Volume and Value) by Type
  2.2.1 Global Cancer Gene Therapy Sales and Market Share by Type (2012-2017)
  2.2.2 Global Cancer Gene Therapy Revenue and Market Share by Type (2012-2017)
2.3 Global Cancer Gene Therapy (Volume and Value) by Region
  2.3.1 Global Cancer Gene Therapy Sales and Market Share by Region (2012-2017)
  2.3.2 Global Cancer Gene Therapy Revenue and Market Share by Region (2012-2017)
2.4 Global Cancer Gene Therapy (Volume) by Application

3 UNITED STATES CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 United States Cancer Gene Therapy Sales and Value (2012-2017)
  3.1.1 United States Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  3.1.2 United States Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  3.1.3 United States Cancer Gene Therapy Sales Price Trend (2012-2017)
3.2 United States Cancer Gene Therapy Sales Volume and Market Share by Players
3.3 United States Cancer Gene Therapy Sales Volume and Market Share by Type
3.4 United States Cancer Gene Therapy Sales Volume and Market Share by Application

4 CHINA CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 China Cancer Gene Therapy Sales and Value (2012-2017)
  4.1.1 China Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  4.1.2 China Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  4.1.3 China Cancer Gene Therapy Sales Price Trend (2012-2017)
4.2 China Cancer Gene Therapy Sales Volume and Market Share by Players
4.3 China Cancer Gene Therapy Sales Volume and Market Share by Type
4.4 China Cancer Gene Therapy Sales Volume and Market Share by Application

5 EUROPE CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Cancer Gene Therapy Sales and Value (2012-2017)
  5.1.1 Europe Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  5.1.2 Europe Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Cancer Gene Therapy Sales Price Trend (2012-2017)
5.2 Europe Cancer Gene Therapy Sales Volume and Market Share by Players
5.3 Europe Cancer Gene Therapy Sales Volume and Market Share by Type
5.4 Europe Cancer Gene Therapy Sales Volume and Market Share by Application

6 JAPAN CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Cancer Gene Therapy Sales and Value (2012-2017)
  6.1.1 Japan Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  6.1.2 Japan Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Cancer Gene Therapy Sales Price Trend (2012-2017)
6.2 Japan Cancer Gene Therapy Sales Volume and Market Share by Players
6.3 Japan Cancer Gene Therapy Sales Volume and Market Share by Type
6.4 Japan Cancer Gene Therapy Sales Volume and Market Share by Application

7 SOUTHEAST ASIA CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Cancer Gene Therapy Sales and Value (2012-2017)
  7.1.1 Southeast Asia Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Cancer Gene Therapy Sales Price Trend (2012-2017)
7.2 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Players
7.3 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Type
7.4 Southeast Asia Cancer Gene Therapy Sales Volume and Market Share by Application

8 INDIA CANCER GENE THERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 India Cancer Gene Therapy Sales and Value (2012-2017)
  8.1.1 India Cancer Gene Therapy Sales and Growth Rate (2012-2017)
  8.1.2 India Cancer Gene Therapy Revenue and Growth Rate (2012-2017)
  8.1.3 India Cancer Gene Therapy Sales Price Trend (2012-2017)
8.2 India Cancer Gene Therapy Sales Volume and Market Share by Players
8.3 India Cancer Gene Therapy Sales Volume and Market Share by Type
8.4 India Cancer Gene Therapy Sales Volume and Market Share by Application

9 GLOBAL CANCER GENE THERAPY PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Adaptimmune
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Cancer Gene Therapy Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Adaptimmune Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 GlaxoSmithKline
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Cancer Gene Therapy Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 GlaxoSmithKline Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Bluebird bio
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Cancer Gene Therapy Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bluebird bio Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Merck
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Cancer Gene Therapy Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Merck Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Celgene
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Cancer Gene Therapy Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Celgene Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 Shanghai Sunway Biotech
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Cancer Gene Therapy Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Shanghai Sunway Biotech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 BioCancell
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Cancer Gene Therapy Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 BioCancell Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Shenzhen SiBiono GeneTech
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Cancer Gene Therapy Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 SynerGene Therapeutics
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Cancer Gene Therapy Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 SynerGene Therapeutics Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 OncoGenex Pharmaceuticals
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Cancer Gene Therapy Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview
9.11 Genelux Corporation
9.12 Cell Genesys
9.13 Advantagene
9.14 GenVec
9.15 BioCancell
9.16 Celgene
9.17 Epeius Biotechnologies
9.18 Introgen Therapeutics
9.19 Ziopharm Oncology
9.20 Shenzhen SiBiono GeneTech
9.21 Altor Bioscience

10 CANCER GENE THERAPY MAUFACTURING COST ANALYSIS

10.1 Cancer Gene Therapy Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Cancer Gene Therapy
10.3 Manufacturing Process Analysis of Cancer Gene Therapy

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Cancer Gene Therapy Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Cancer Gene Therapy Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL CANCER GENE THERAPY MARKET FORECAST (2017-2022)

14.1 Global Cancer Gene Therapy Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Cancer Gene Therapy Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Cancer Gene Therapy Price and Trend Forecast (2017-2022)
14.2 Global Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Cancer Gene Therapy Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Cancer Gene Therapy Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Cancer Gene Therapy Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Cancer Gene Therapy Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Cancer Gene Therapy Sales Forecast by Type (2017-2022)
  14.3.2 Global Cancer Gene Therapy Revenue Forecast by Type (2017-2022)
  14.3.3 Global Cancer Gene Therapy Price Forecast by Type (2017-2022)
14.4 Global Cancer Gene Therapy Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cancer Gene Therapy
Figure Global Cancer Gene Therapy Sales Volume Comparison (Units) by Type (2012-2022)
Figure Global Cancer Gene Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Gene Induced Immunotherapy Product Picture
Figure Oncolytic Virotherapy Product Picture
Figure Gene Transfer Product Picture
Figure Global Cancer Gene Therapy Sales Comparison (Units) by Application (2012-2022)
Figure Global Sales Market Share of Cancer Gene Therapy by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Diagnostics Centers Examples
Table Key Downstream Customer in Diagnostics Centers
Figure Research Institutes Examples
Table Key Downstream Customer in Research Institutes
Figure Global Cancer Gene Therapy Market Size (Million USD) by Regions (2012-2022)
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Cancer Gene Therapy Sales Volume (Units) and Growth Rate (2012-2022)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Cancer Gene Therapy Sales Volume (Units) (2012-2017)
Table Global Cancer Gene Therapy Sales (Units) of Key Players/Suppliers (2012-2017)
Table Global Cancer Gene Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Cancer Gene Therapy Sales Share by Players/Suppliers
Figure 2017 Cancer Gene Therapy Sales Share by Players/Suppliers
Figure Global Cancer Gene Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Cancer Gene Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Cancer Gene Therapy Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Cancer Gene Therapy Revenue Share by Players
Table 2017 Global Cancer Gene Therapy Revenue Share by Players
Table Global Cancer Gene Therapy Sales (Units) and Market Share by Type (2012-2017)
Table Global Cancer Gene Therapy Sales Share (Units) by Type (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure Global Cancer Gene Therapy Sales Growth Rate by Type (2012-2017)
Table Global Cancer Gene Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Cancer Gene Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Type (2012-2017)
Figure Global Cancer Gene Therapy Revenue Growth Rate by Type (2012-2017)
Table Global Cancer Gene Therapy Sales Volume (Units) and Market Share by Region (2012-2017)
Table Global Cancer Gene Therapy Sales Share by Region (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure Global Cancer Gene Therapy Sales Growth Rate by Region in 2016
Table Global Cancer Gene Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Cancer Gene Therapy Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure Global Cancer Gene Therapy Revenue Growth Rate by Region in 2016
Table Global Cancer Gene Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Cancer Gene Therapy Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Cancer Gene Therapy by Region (2012-2017)
Figure Global Cancer Gene Therapy Revenue Market Share by Region in 2016
Table Global Cancer Gene Therapy Sales Volume (Units) and Market Share by Application (2012-2017)
Table Global Cancer Gene Therapy Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Cancer Gene Therapy by Application (2012-2017)
Figure Global Cancer Gene Therapy Sales Market Share by Application (2012-2017)
Figure United States Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table United States Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table United States Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure United States Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table United States Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table United States Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure United States Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table United States Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table United States Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure United States Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure China Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure China Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table China Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table China Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure China Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table China Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table China Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure China Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table China Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table China Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure China Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Europe Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table Europe Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table Europe Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure Europe Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table Europe Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table Europe Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Europe Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Europe Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table Europe Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Europe Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Japan Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure Japan Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table Japan Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Japan Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Japan Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table Japan Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Japan Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure Southeast Asia Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table Southeast Asia Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table Southeast Asia Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Figure India Cancer Gene Therapy Sales (Units) and Growth Rate (2012-2017)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Cancer Gene Therapy Sales Price (K USD/Unit) Trend (2012-2017)
Table India Cancer Gene Therapy Sales Volume (Units) by Players (2012-2017)
Table India Cancer Gene Therapy Sales Volume Market Share by Players (2012-2017)
Figure India Cancer Gene Therapy Sales Volume Market Share by Players in 2016
Table India Cancer Gene Therapy Sales Volume (Units) by Type (2012-2017)
Table India Cancer Gene Therapy Sales Volume Market Share by Type (2012-2017)
Figure India Cancer Gene Therapy Sales Volume Market Share by Type in 2016
Table India Cancer Gene Therapy Sales Volume (Units) by Application (2012-2017)
Table India Cancer Gene Therapy Sales Volume Market Share by Application (2012-2017)
Figure India Cancer Gene Therapy Sales Volume Market Share by Application in 2016
Table Adaptimmune Basic Information List
Table Adaptimmune Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Adaptimmune Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Adaptimmune Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure GlaxoSmithKline Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Bluebird bio Basic Information List
Table Bluebird bio Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Bluebird bio Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Bluebird bio Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Merck Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Merck Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Merck Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Celgene Basic Information List
Table Celgene Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Celgene Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Celgene Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Celgene Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Shanghai Sunway Biotech Basic Information List
Table Shanghai Sunway Biotech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Shanghai Sunway Biotech Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Shanghai Sunway Biotech Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table BioCancell Basic Information List
Table BioCancell Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure BioCancell Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure BioCancell Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Shenzhen SiBiono GeneTech Basic Information List
Table Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure Shenzhen SiBiono GeneTech Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table SynerGene Therapeutics Basic Information List
Table SynerGene Therapeutics Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure SynerGene Therapeutics Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure SynerGene Therapeutics Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table OncoGenex Pharmaceuticals Basic Information List
Table OncoGenex Pharmaceuticals Cancer Gene Therapy Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Growth Rate (2012-2017)
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Sales Global Market Share (2012-2017
Figure OncoGenex Pharmaceuticals Cancer Gene Therapy Revenue Global Market Share (2012-2017)
Table Genelux Corporation Basic Information List
Table Cell Genesys Basic Information List
Table Advantagene Basic Information List
Table GenVec Basic Information List
Table BioCancell Basic Information List
Table Celgene Basic Information List
Table Epeius Biotechnologies Basic Information List
Table Introgen Therapeutics Basic Information List
Table Ziopharm Oncology Basic Information List
Table Shenzhen SiBiono GeneTech Basic Information List
Table Altor Bioscience Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Gene Therapy
Figure Manufacturing Process Analysis of Cancer Gene Therapy
Figure Cancer Gene Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Gene Therapy Major Players in 2016
Table Major Buyers of Cancer Gene Therapy
Table Distributors/Traders List
Figure Global Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Cancer Gene Therapy Price (K USD/Unit) and Trend Forecast (2017-2022)
Table Global Cancer Gene Therapy Sales Volume (Units) Forecast by Regions (2017-2022)
Figure Global Cancer Gene Therapy Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Cancer Gene Therapy Sales Volume Market Share Forecast by Regions in 2022
Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Regions in 2022
Figure United States Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure United States Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure China Cancer Gene Therapy Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Europe Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Japan Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Cancer Gene Therapy Sales Volume (Units) and Growth Rate Forecast (2017-2022)
Figure India Cancer Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Cancer Gene Therapy Sales (Units) Forecast by Type (2017-2022)
Figure Global Cancer Gene Therapy Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Cancer Gene Therapy Revenue Market Share Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Price (K USD/Unit) Forecast by Type (2017-2022)
Table Global Cancer Gene Therapy Sales (Units) Forecast by Application (2017-2022)
Figure Global Cancer Gene Therapy Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources